These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 21848200
21. Cost and effectiveness of cardiovascular prevention. Boyar A. Am J Cardiol; 2007 Nov 01; 100(9):1492-4; author reply 1494-5. PubMed ID: 17950815 [No Abstract] [Full Text] [Related]
22. Adherence to statin therapy: the key to survival? Andersohn F. Int J Clin Pract; 2010 Jun 01; 64(7):843-7. PubMed ID: 20584217 [No Abstract] [Full Text] [Related]
23. Study stirs debate about statin use in those without high cholesterol. Mayo Clin Womens Healthsource; 2009 Apr 01; 13(4):3. PubMed ID: 19255535 [No Abstract] [Full Text] [Related]
25. Statin therapy in patients with type 2 diabetes. Lo V, Noviasky J, Nashelsky J. Am Fam Physician; 2005 Sep 01; 72(5):866-8. PubMed ID: 16156346 [No Abstract] [Full Text] [Related]
26. Statin therapy: when to think twice. Wahawisan J, Tovar JM, Granberry MC. J Fam Pract; 2013 Dec 01; 62(12):726-32. PubMed ID: 24340334 [No Abstract] [Full Text] [Related]
27. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Pittman DG, Chen W, Bowlin SJ, Foody JM. Am J Cardiol; 2011 Jun 01; 107(11):1662-6. PubMed ID: 21439533 [Abstract] [Full Text] [Related]
28. Are statin effects mediated through, or in spite of, their cholesterol-lowering action? Mascitelli L, Pezzetta F, Goldstein MR. Angiology; 2009 Jun 01; 60(2):262-3. PubMed ID: 19141486 [No Abstract] [Full Text] [Related]
29. PHARMAC and statins--getting the best population health gains. Moodie P, Dougherty S, Metcalfe S. N Z Med J; 2006 Jul 21; 119(1238):U2092. PubMed ID: 16868585 [No Abstract] [Full Text] [Related]
30. Statin therapy in the elderly: a review. Szadkowska I, Stanczyk A, Aronow WS, Kowalski J, Pawlicki L, Ahmed A, Banach M. Arch Gerontol Geriatr; 2010 Jul 21; 50(1):114-8. PubMed ID: 19217673 [Abstract] [Full Text] [Related]
31. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E. Clin Ther; 2008 Nov 21; 30(11):2167-79. PubMed ID: 19108805 [Abstract] [Full Text] [Related]
32. Application of the 1998 Canadian cholesterol guidelines to a military population: health benefits and cost effectiveness of improved cholesterol management. Spaans JN, Coyle D, Fodor G, Nair R, Vaillancourt R, Grover SA, Coupal L. Can J Cardiol; 2003 Jun 21; 19(7):790-6. PubMed ID: 12813612 [Abstract] [Full Text] [Related]
33. [Lipid therapy is effective in concomitant risk. In this way statins can be prescribed in a budget-appropriate manner]. MMW Fortschr Med; 2000 Mar 30; 142(13):48-9. PubMed ID: 10783625 [No Abstract] [Full Text] [Related]
35. Using cost-effectiveness to target cholesterol reduction. Beaird J. Ann Intern Med; 2001 Aug 21; 135(4):299-300. PubMed ID: 11511147 [No Abstract] [Full Text] [Related]
37. Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial. Ohsfeldt RL, Gandhi SK, Smolen LJ, Jensen MM, Fox KM, Gold A, Hsia J. J Med Econ; 2010 Aug 21; 13(3):428-37. PubMed ID: 20662625 [Abstract] [Full Text] [Related]
39. The economics of cardiovascular disease in the United States. Chen J, Rizzo JA. Crit Care Clin; 2012 Jan 21; 28(1):77-88, vi. PubMed ID: 22123100 [Abstract] [Full Text] [Related]